Skip to main content
. 2019 Sep 26;8(5):83–94. doi: 10.5527/wjn.v8.i5.83

Figure 2.

Figure 2

Potential therapies based on targeting the key regulatory molecules of canonical Wnt /β-catenin signaling in urothelial tumorigenesis.